Addus HomeCare Co. (NASDAQ:ADUS) Receives $103.00 Consensus Target Price from Brokerages

Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $103.00.

Several brokerages have recently issued reports on ADUS. Barclays lowered shares of Addus HomeCare from an "equal weight" rating to an "underweight" rating and set a $83.00 price target for the company. in a research note on Tuesday. William Blair restated an "outperform" rating on shares of Addus HomeCare in a research note on Monday, February 5th. Oppenheimer reiterated an "outperform" rating and issued a $118.00 price objective on shares of Addus HomeCare in a research note on Tuesday, March 26th. Finally, Royal Bank of Canada reiterated an "outperform" rating and issued a $102.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 29th.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock traded up $2.84 during mid-day trading on Friday, hitting $94.54. 205,950 shares of the stock were exchanged, compared to its average volume of 121,167. Addus HomeCare has a 12 month low of $77.30 and a 12 month high of $114.97. The company has a 50-day simple moving average of $97.69 and a 200 day simple moving average of $91.59. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. The company has a market capitalization of $1.53 billion, a P/E ratio of 24.62, a P/E/G ratio of 1.88 and a beta of 0.96.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, February 26th. The company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.17. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. The company had revenue of $276.35 million during the quarter, compared to analyst estimates of $274.02 million. Sell-side analysts anticipate that Addus HomeCare will post 4.38 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Mesirow Financial Investment Management Inc. bought a new position in Addus HomeCare in the first quarter worth approximately $234,000. Assenagon Asset Management S.A. increased its stake in shares of Addus HomeCare by 78.8% in the first quarter. Assenagon Asset Management S.A. now owns 112,256 shares of the company's stock worth $11,601,000 after purchasing an additional 49,483 shares in the last quarter. Chatham Capital Group Inc. increased its stake in shares of Addus HomeCare by 15.1% in the first quarter. Chatham Capital Group Inc. now owns 21,344 shares of the company's stock worth $2,206,000 after purchasing an additional 2,795 shares in the last quarter. Guidance Capital Inc. increased its stake in shares of Addus HomeCare by 71.6% in the first quarter. Guidance Capital Inc. now owns 4,783 shares of the company's stock worth $463,000 after purchasing an additional 1,996 shares in the last quarter. Finally, Bridge City Capital LLC increased its stake in shares of Addus HomeCare by 46.4% in the first quarter. Bridge City Capital LLC now owns 30,999 shares of the company's stock worth $3,203,000 after purchasing an additional 9,819 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.